NEWS & EVENTS
- Sort By:
Dr. Ramsey-Goldman receives 2017 Evelyn V. Hess Award
Dr. Ramsey-Goldman is globally recognized for her clinical skills, diversity of her research efforts and focus on lupus. Over the past 30 years, she has worked at the interface between immunology and rheumatology, and has undertaken several major committee assignments for the American College of Rheumatology (ACR), National Institutes of Health (NIH), and the Systemic Lupus International Collaborating Clinics (SLICC).
Dr. M. Urowitz receives ACR 2017 Distinguished Clinical Investigator Award
Dr. M. Urowitz has recieved the American College of Rheumatology’s 2017 Distinguished Clinical Investigator Award. This distinction is awarded to a clinical scientist making outstanding contributions to the field of rheumatology. This award was known as the Clinical Research Award prior to 2006.
Dr. W. Winn Chatham receives ACR 2017 Distinguished Clinician Scholar Award
Dr. W. Winn Chatham has received the American College of Rheumatology’s 2017 Distinguished Clinician Scholar Award. This distinction is awarded to a rheumatologist who has made outstanding contributions in clinical medicine, clinical scholarship, or education.
Dr. Dafna Gladman receives 2016 Evelyn V. Hess Award
The winner of this year’s Hess award is Dafna Gladman, MD, who is a rheumatologist at the Center for Prognosis Studies, Toronto Western Hospital, Toronto Canada. Dr. Gladman is co-director of the University of Toronto Lupus Clinic and has undertaken numerous and wide-ranging studies of the disease including genetic analyses, studies of morbidity and the development of an internationally-recognized activity index for lupus.
SLICC Participant Newsletter Vol. 8
We are happy to report that many of our participants have been followed for more than 10 years. It is hard to believe this registry began in 2000. Our very first enrolled patient is now at 15 years of follow-up. Achieving our goal of 1800 participants has allowed us to study the long term effects of living with lupus. One of the main goals of our research is to look at the risk factors associate with heart disease in lupus.
SLICC Participant Newsletter Vol. 7
We are happy to report we have reached our recruitment target of 1800 patients. This constitutes the world’s largest cohort of newly diagnosed SLE patients assembled to date!
Achieving our goal of 1800 patients has marked the end of the beginning as we are now in the long term follow phase of the study. This will allow us to accurately document the many complications associated with SLE.
